Clinical Trial Update: RWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL)

View source ↗

Summary

Novartis is conducting ASC4REAL, a prospective real-world study of Asciminib in Saudi Arabia to evaluate effectiveness, tolerability, and adherence in chronic m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia Chronic Phase

Drugs mentioned

• Asciminib (asciminib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Myelogenous Leukemia in Chronic Phase | Status: RECRUITING